Lv1
68 积分 2022-10-28 加入
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
11天前
已完结
In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma
11天前
已完结
Discovery and validation of human genomic safe harbor sites for gene and cell therapies
13天前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
2个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
2个月前
已完结
Allogeneic CD19 CAR T cells armed with an anti-rejection CD70 CAR overcome antigen escape and evade alloimmune responses
3个月前
已关闭
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies
4个月前
已完结
Allogeneic CD19 CAR T cells armed with an anti-rejection CD70 CAR overcome antigen escape and evade alloimmune responses
4个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
4个月前
已完结
The persistence and antitumor efficacy of CAR-T cells are modulated by tonic signaling within the CDR
4个月前
已完结
皖公网安备34019202002308
